N@N

Market Maker Surveillance Report. PPHM, NAK, CHTP, VWDRY, JAG, HEK, Winning Stocks With Lowest Price Friction For Tuesday, Sep

September 4, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4102 companies with "abnormal" market making, 2870 companies with positive Friction Factors and 2602 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Peregrine Pharmaceuticals Inc (NASDAQ:PPHM), NORTHERN DYNASTY MINERALS (AMEX:NAK), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Vestas Wind Systems A/S (OTC:VWDRY), Jaguar Mining Inc (NYSE:JAG), Heckmann Corp (NYSE:HEK). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PPHM    $0.410    16.14%    2,541,318    49.67%    2,287,894    44.71%    253,424      6,181   
  NAK     $0.690    24.38%    510,779      30.66%    468,264      28.10%    42,515       616     
  CHTP    $0.250    23.81%    1,025,204    51.44%    946,886      47.51%    78,318       3,133   
  VWDRY   $0.380    16.45%    51,272       46.84%    48,981       44.74%    2,291        60      
  JAG     $0.160    15.92%    886,549      37.70%    723,995      30.79%    162,554      10,160  
  HEK     $1.040    38.66%    8,389,923    36.70%    7,915,717    34.63%    474,206      4,560   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PPHM with a dollar gain Tuesday of $0.41000 and a Friction Factor of 6,181 shares. That means that it only took 6,181 more shares of buying than selling to move PPHM higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM) - Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The company develops clinical programs with its novel compounds bavituximab and Cotara, which are the clinical candidates under its anti-phosphatidylserine therapeutics and tumor necrosis therapy platforms. Its pipeline products comprise Bavituximab Plus Docetaxel, and Bavituximab plus carboplatin and paclitaxel, which are Phase II clinical trial products for treating advanced breast cancer patients; and Bavituximab plus carboplatin and paclitaxel, a Phase II clinical trial product for the treatment of non-small cell lung cancer, as well as Bavituximab, which is in Phase I monotherapy repeat dose safety study for treating solid tumor cancers, and in Phase Ib repeat dose safety study for the treatment of chronic hepatitis C virus infection co-infected with HIV. In addition, its pipeline products include Cotara, a product in Phase II, as well as a dosimetry and dose confirmation study for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Further, Peregrine, through its wholly owned subsidiary, Avid Bioservices, Inc., provides contract manufacturing services for biotechnology and biopharmaceutical companies, from pre-clinical drug supplies up through commercial-scale drug manufacture. Further, it provides services in support of Peregrine's product pipeline, including manufacture and scale-up of pre-clinical and clinical drug supplies. The company was founded in 1981 and is based in Tustin, California.

NORTHERN DYNASTY MINERALS (AMEX:NAK) - Northern Dynasty Minerals Ltd., through its subsidiaries, engages in the exploration of mineral properties in the United States. It owns 50% interest in the Pebble copper-gold- molybdenum project located in Alaska, the United States. The company was formerly known as Northern Dynasty Explorations Ltd. and changed its name to Northern Dynasty Minerals Ltd. in October 1997. Northern Dynasty Minerals Ltd. was founded in 1983 and is headquartered in Vancouver, Canada.

Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Vestas Wind Systems A/S (OTC:VWDRY) - Vestas Wind Systems A/S engages in the development, manufacture, sale, and maintenance of wind technology that uses the energy of the wind to generate electricity. It offers wind turbines and wind power systems. The company also provides planning, installation, operation, and maintenance services. Vestas Wind Systems A/S has a strategic partnership with Marafeq to develop wind energy projects in Syria. It operates in Europe, the Americas, and the Asia Pacific. The company was founded in 1898 and is headquartered in Randers, Denmark.

Jaguar Mining Inc (NYSE:JAG) - Jaguar Mining Inc. engages in the production of gold, as well as in the acquisition, exploration, development, and operation of gold mineral properties in Brazil. It holds interests in the Turmalina, Paciencia, Sabara, and Caete gold projects in the state of Minas Gerais. The company also holds interests in the Gurupi Project located in the state of Maranhao. In addition, it has a joint venture agreement with Xstrata plc to explore the Pedra Branca Project located in the state of Ceara, northeastern Brazil. The company was founded in 1984 and is headquartered in Concord, New Hampshire.

Heckmann Corp (NYSE:HEK) - Heckmann Corporation, a holding company, acquires or makes investments in various businesses. The company, through its subsidiary, China Water & Drinks, Inc., engages in the manufacture and sale of bottled water products in the Peoples Republic of China. It offers bottled water products, including purified water, mineralized water, and oxygenated water under the Darcunk (Absolutely Pure) and Grand Canyon brand names. The company serves primarily beverage companies and servicing companies, as well as provides private label bottled products to companies in the service industry, such as hotels and casinos. Heckmann Corporation, through its other subsidiary, Heckmann Water Resources Corporation, engages in the saltwater disposal, treatment, and pipeline transportation businesses in Texas and Louisiana that serve customers to dispose saltwater and frac fluid generated in the oil and gas operations. As of March 11, 2010, it operated a 50 mile pipeline in the Haynesville Shale in east Texas and northwest Louisiana. In addition, the company holds approximately 7% of equity in Underground Solutions, Inc., a water infrastructure and pipeline company located in Poway, California; and an investment in China Bottles, Inc., a bottle equipment manufacturing company in China. Heckmann Corporation is headquartered in Palm Desert, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net